pharma · Colon Carcinoma Metastatic in the Liver · Metastatic Melanoma · VCNX
Vaccinex
VACCINEX, INC.
Vaccinex is a pharma organization headquartered in Rochester, USA. It trades on NYSE under ticker VCNX. Primary therapeutic focus areas include Colon Carcinoma Metastatic in the Liver, Metastatic Melanoma, Metastatic Pan
1895 Mt Hope Ave, Rochester, New York 14620, US HQ
28 Employees
Public company Type
VCNX · NYSE Ticker
Company details
- Status
- Public
- HQ
- 1895 Mt Hope Ave, Rochester, New York 14620, US
- Employees
- 28
- Programs
- 11
- Drugs
- 8
- Patents
- 41
Dendritic Cell (DC1) Vaccine
Phase 1 · mab · HER2-positive Breast Cancer
Dendritic Cell (DC1) Vaccine for HER2-positive Breast Cancer is a Phase 1 program (mab) at VACCINEX, INC. with 1 ClinicalTrials.gov record(s).
Internal code MCC-21378
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- VACCINEX, INC.
- Phase
- Phase 1
- Modality
- mab
- Indication
- HER2-positive Breast Cancer
- Status
- active
- Trials
- 1